Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines
Clinical trial NCT02236312 · COMPLETED
Trial details
- NCT number
- NCT02236312
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2014-11-01
- Enrollment
- 359
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.